Physician profile
Daniel P Miller
NPI 1164784757
$1,261.01
in general payments reported to CMS, 2019-2025
21 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.24 · 2020: $24.73 · 2021: $99.00 · 2022: $190 · 2023: $513 · 2024: $188 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $317.78 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $251.40 | 2021-2023 | Puraply |
| Averitas Pharma INC. | $142.66 | 2023-2024 | Qutenza |
| Nevro Corp. | $114.61 | 2023-2024 | Senza |
| Globus Medical, INC. | $73.18 | 2025 | Omnia, Senza |
| Nabriva Therapeutics, Plc | $44.11 | 2022 | |
| Ani Pharmaceuticals, INC. | $40.53 | 2025 | Purified Cortrophin Gel |
| Abbott Laboratories | $39.44 | 2023-2024 | Proclaim |
| Peerless Surgical INC. | $25.48 | 2019 | |
| Zyla Life Sciences, INC. | $24.73 | 2020 | |
| Orthofix Medical, INC. | $24.73 | 2022 | |
| Abbvie INC. | $24.47 | 2023 | |
| Treace Medical Concepts, INC. | $21.45 | 2025 | |
| Zimvie INC. | $20.88 | 2022 | |
| Horizon Therapeutics Plc | $16.88 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16.70 | 2022 | |
| Mimedx Group, INC. | $15.64 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.27 | 2023 | Jublia |
| Sebela Pharmaceuticals INC. | $13.19 | 2022 | |
| Smith+Nephew, INC. | $12.88 | 2019 | |
| Glenmark Therapeutics INC. | $5.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.